Fei Xiao

5.6k total citations
126 papers, 1.7k citations indexed

About

Fei Xiao is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Fei Xiao has authored 126 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 41 papers in Pulmonary and Respiratory Medicine and 19 papers in Cancer Research. Recurrent topics in Fei Xiao's work include Lung Cancer Diagnosis and Treatment (16 papers), RNA modifications and cancer (10 papers) and Circular RNAs in diseases (9 papers). Fei Xiao is often cited by papers focused on Lung Cancer Diagnosis and Treatment (16 papers), RNA modifications and cancer (10 papers) and Circular RNAs in diseases (9 papers). Fei Xiao collaborates with scholars based in China, United States and Australia. Fei Xiao's co-authors include Lihui Zou, Valerie S. LeBleu, Antonios Chronopoulos, Kathleen M. McAndrews, Fernanda G. Kugeratski, Raghu Kalluri, Junhua Jin, Deruo Liu, Qi Pan and Yanming Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Fei Xiao

119 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fei Xiao China 24 898 493 338 189 157 126 1.7k
Yuriy O. Alekseyev United States 21 781 0.9× 300 0.6× 333 1.0× 207 1.1× 73 0.5× 48 1.3k
Ruiqi Wang China 23 920 1.0× 553 1.1× 150 0.4× 164 0.9× 109 0.7× 115 1.6k
Zheng Lin China 25 748 0.8× 298 0.6× 257 0.8× 152 0.8× 245 1.6× 128 1.7k
Meng Lv China 25 657 0.7× 369 0.7× 280 0.8× 466 2.5× 172 1.1× 103 1.8k
Joanna Chorostowska‐Wynimko Poland 22 518 0.6× 633 1.3× 564 1.7× 387 2.0× 103 0.7× 143 1.6k
Mingjie Wang China 22 747 0.8× 220 0.4× 266 0.8× 147 0.8× 237 1.5× 96 1.7k
Xiong Chen China 19 853 0.9× 417 0.8× 667 2.0× 450 2.4× 245 1.6× 80 1.9k
Ying Cao China 21 797 0.9× 522 1.1× 154 0.5× 190 1.0× 123 0.8× 94 1.6k
Chengshui Chen China 22 734 0.8× 192 0.4× 404 1.2× 168 0.9× 109 0.7× 92 1.5k
Zhuo Li China 21 747 0.8× 497 1.0× 220 0.7× 366 1.9× 336 2.1× 88 1.8k

Countries citing papers authored by Fei Xiao

Since Specialization
Citations

This map shows the geographic impact of Fei Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Xiao more than expected).

Fields of papers citing papers by Fei Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Xiao. The network helps show where Fei Xiao may publish in the future.

Co-authorship network of co-authors of Fei Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Xiao. A scholar is included among the top collaborators of Fei Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Xiao. Fei Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Junying, Mengping Chen, Xin Li, et al.. (2025). Targeting deubiquitinase USP7-mediated stabilization of XPO1 contributes to the anti-myeloma effects of selinexor. Journal of Translational Medicine. 23(1). 62–62. 2 indexed citations
3.
Jiang, Yan, et al.. (2024). PFOS and PFOSA induce oxidative stress-mediated cardiac defects in zebrafish via PPARγ and AHR pathways, respectively. The Science of The Total Environment. 951. 175716–175716. 5 indexed citations
4.
Zhang, Zaifeng, Lili Zhang, Ru Feng, et al.. (2024). Comprehensive analysis of m6A methylome alterations after azacytidine plus venetoclax treatment for acute myeloid leukemia by nanopore sequencing. Computational and Structural Biotechnology Journal. 23. 1144–1153. 3 indexed citations
5.
Guo, Yue Leon, Zaifeng Zhang, Chang Li, et al.. (2024). mRNA m5C Alteration in Azacitidine Demethylation Treatment of Acute Myeloid Leukemia. Molecular Carcinogenesis. 64(3). 502–512. 3 indexed citations
6.
7.
Li, Liheng, et al.. (2024). Association Between Preoperative Sleep Disturbance and Postoperative Delirium in Elderly: A Retrospective Cohort Study. Nature and Science of Sleep. Volume 16. 389–400. 5 indexed citations
8.
Zhang, Lili, Jian Cui, Qi An, et al.. (2023). Small extrachromosomal circular DNAs as biomarkers for multi‐cancer diagnosis and monitoring. Clinical and Translational Medicine. 13(9). e1393–e1393. 19 indexed citations
9.
He, Yujian, et al.. (2023). Red cell distribution width to albumin ratio predicts treatment failure in peritoneal dialysis‐associated peritonitis. Therapeutic Apheresis and Dialysis. 28(3). 399–408. 1 indexed citations
10.
Wang, Qingchen, Chang Li, Lili Zhang, et al.. (2023). IGH rod-like tracer: An AlphaFold2 structural similarity extraction-based predictive biomarker for MRD monitoring in pre-B-ALL. iScience. 26(7). 107107–107107. 1 indexed citations
11.
Pan, Qi, et al.. (2023). Medications and medical expenditures for diabetic patients with osteoporosis in Beijing, China: A retrospective study. Diabetes Research and Clinical Practice. 206. 110980–110980. 3 indexed citations
12.
Xiao, Fei, Yanling Wei, Congying Song, et al.. (2023). Cystatin C–based estimated glomerular filtration rate and risk of stroke in the general population: a prospective cohort study. Clinical Kidney Journal. 16(11). 2059–2071. 6 indexed citations
13.
Zhang, Fan, Leiming Wang, Wanru Duan, et al.. (2023). Mutational landscape of primary spinal cord astrocytoma. The Journal of Pathology. 260(3). 317–328. 5 indexed citations
14.
Pan, Qi, Lina Zhang, Huan Chen, et al.. (2023). How does diabetic peripheral neuropathy impact patients' burden of illness and the economy? A retrospective study in Beijing, China. Frontiers in Public Health. 11. 1164536–1164536. 7 indexed citations
15.
McAndrews, Kathleen M., Fei Xiao, Antonios Chronopoulos, et al.. (2021). Exosome-mediated delivery of CRISPR/Cas9 for targeting of oncogenic KrasG12D in pancreatic cancer. Life Science Alliance. 4(9). e202000875–e202000875. 160 indexed citations
16.
Xu, Yanyan, Hongliang Sun, Zhenguo Huang, et al.. (2021). The utility of simultaneous CT-guided localization for multiple pulmonary nodules using microcoil before video-assisted thoracic surgery. BMC Pulmonary Medicine. 21(1). 39–39. 12 indexed citations
17.
Li, Shan, Sridhar Nonavinkere Srivatsan, Yuhao Chen, et al.. (2021). Nonsense-Mediated RNA Decay Is a Unique Vulnerability of Cancer Cells Harboring SF3B1 or U2AF1 Mutations. Cancer Research. 81(17). 4499–4513. 37 indexed citations
18.
Fan, Jingwen, et al.. (2021). TSH Combined with TSHR Aggravates Diabetic Peripheral Neuropathy by Promoting Oxidative Stress and Apoptosis in Schwann Cells. Oxidative Medicine and Cellular Longevity. 2021(1). 21 indexed citations
19.
Zhu, Mei, Yicheng Ma, Fei Xiao, et al.. (2018). MicroRNA-410-5p exacerbates high-fat diet-induced cardiac remodeling in mice in an endocrine fashion. Scientific Reports. 8(1). 8780–8780. 37 indexed citations
20.
Li, Gang, Ling Tian, Yuquan Wei, et al.. (2005). [Fusion expression, purification and bioassay of IFN-gamma inducible protein-10 and thioredoxin gene in E. coli].. PubMed. 22(3). 535–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuriy O. Alekseyev Breakdown of academic impact, for papers by Ruiqi Wang Breakdown of academic impact, for papers by Zheng Lin Breakdown of academic impact, for papers by Meng Lv Breakdown of academic impact, for papers by Joanna Chorostowska‐Wynimko Breakdown of academic impact, for papers by Mingjie Wang Breakdown of academic impact, for papers by Xiong Chen Breakdown of academic impact, for papers by Ying Cao Breakdown of academic impact, for papers by Chengshui Chen Breakdown of academic impact, for papers by Zhuo Li
Rankless by CCL
2026